SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-408779
Filing Date
2012-09-28
Accepted
2012-09-28 15:09:13
Documents
13
Period of Report
2012-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q d399300d10q.htm 10-Q 264643
2 EX-10.1 d399300dex101.htm EX-10.1 22476
3 EX-10.2 d399300dex102.htm EX-10.2 22453
4 EX-31.1 d399300dex311.htm EX-31.1 9519
5 EX-31.2 d399300dex312.htm EX-31.2 9576
6 EX-32 d399300dex32.htm EX-32 4894
13 GRAPHIC g399300g56c89.jpg GRAPHIC 6965
  Complete submission text file 0001193125-12-408779.txt   2550067

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT neog-20120831.xml EX-101.INS 234366
8 XBRL TAXONOMY EXTENSION SCHEMA neog-20120831.xsd EX-101.SCH 29951
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20120831_cal.xml EX-101.CAL 49780
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20120831_def.xml EX-101.DEF 169770
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20120831_lab.xml EX-101.LAB 249959
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20120831_pre.xml EX-101.PRE 203367
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 121116313
SIC: 2835 In Vitro & In Vivo Diagnostic Substances